New cancer clinical trial: Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.

Published on: August 15, 2018 at 12:00PM
Conditions:   Prostate Cancer;   Benign Prostatic Hypertrophy;   Bladder Stones;   Kidney Stones
Intervention:   Diagnostic Test: NV-VPAC1 PCa Urine Diagnostic Test
Sponsors:   Intermountain Health Care, Inc.;   NuView Diagnostics
Not yet recruiting
https://ift.tt/2vMFBVJ